Additionally, the evaluation of the DYRK1A-SRSF6-TNNT2 pathway in myocardial tissue from DS individuals showed elevated levels of phosphorylated SRSF6 and increased expression of fetal TNNT2 variants (Quiñones-Lombraña and Blanco, 2019). This evidence concerns the gene SRSF6 and Dravet syndrome.